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0. Abstract 
 
This article seeks to address the prevailing issue of how to measure specific process 
components of psychobiological stress responses. Particularly the change of cortisol 
secretion due to stress exposure has been discussed as an endophenotype of many 
psychosomatic health outcomes. To assess its process components, a large variety 
of non-compartmental parameters (i.e., composite measures of substance 
concentrations at different points in time) like the area under the concentration-time 
curve (AUC) are commonly utilized. However, a systematic evaluation and validation 
of these parameters based on a physiologically plausible model of cortisol secretion 
has not been performed so far. 
Thus, a population pharmacokinetic (mixed-effects stochastic differential equation) 
model was developed and fitted to densely sampled salivary cortisol data of 10 males 
from Montreal, Canada, and sparsely sampled data of 200 mixed-sex participants 
from Dresden, Germany, who completed the Trier Social Stress Test (TSST). 
Besides the two major process components representing (1) stress-related cortisol 
secretion (reactivity) and (2) cortisol elimination (recovery), the model incorporates 
two additional, often disregarded components: (3) the secretory delay after stress 
onset, and (4) deviations from the projected steady-state concentration due to stress-
unrelated fluctuations of cortisol secretion. 
The fitted model (R2 = 99%) was thereafter used to investigate the correlation 
structure of the four individually varying, and readily interpretable model parameters 
and eleven popular non-compartmental parameters. Based on these analyses, we 
recommend to use the minimum-maximum cortisol difference and the minimum 
concentration as proxy measures of reactivity and recovery, respectively. Finally, 
statistical power analyses of the reactivity-related sex effect illustrate the 
consequences of using impure non-compartmental measures of the different process 
components that underlie the cortisol stress response.  
Miller et al. (in press). https://doi.org/10.1016/j.psyneuen.2017.12.019 
	 3	
1. Introduction 
 
In hominids two major systems mediate psychophysiological responses to acute 
environmental stress; the sympathetic adrenal medullary (SAM) system and the 
hypothalamic pituitary-adrenal (HPA) axis. While responses of the SAM system are 
easily inducible by most effortful situations, HPA responses require more effective 
stressors that are characterized by unpredictability and ego-threat (Dickerson & 
Kemeny, 2004, see also Koolhaas et al., 2011). Although a secretory cascade of 
multiple hormones accompanies such HPA responses, their most popular indicator is 
a transient stress-related change of cortisol concentrations. This change features a 
considerable portion of trait variance due to gene-environment interaction 
(Federenko et al., 2004, Hankin et al., 2015) and will be henceforth referred to as 
cortisol stress response. It is characterized by a phase of reactivity ranging from a 
basal pre-stress concentration to the post-stress concentration peak, and a phase of 
recovery, that follows this concentration peak until the basal concentration is reached 
again (see Figure 1; Kirschbaum et al. 1993, Linden et al., 1997). 
 
Figure 1. Change of mean cortisol concentrations in (A) blood serum, and (B) saliva in response to a 
stress induction protocol or bolus saline injection (NaCl). Data were obtained from 20 healthy males (age: 
24.7 +- 3.3 years), who completed both interventions (Kirschbaum et al., 1993). 
Apart from the superior specificity of cortisol as compared to other hormones 
(Koolhaas et al., 2011), another methodological advantage has promoted its 
popularity as the primary biomarker of psychosocial stress: Traditionally, the 
monitoring of cortisol concentrations has relied on the repeated sampling of blood 
specimens by invasive venipuncture procedures. Apart from several infrastructural 
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disadvantages (Levine et al., 2007), however, venipuncture was found to selectively 
act as a potent physiological stressor (Weckesser et al., 2015) which rendered this 
method less practical for population-wide assessments of the cortisol stress 
response. In search of a more easily accessible medium, saliva specimens were 
found to contain lower cortisol concentrations, whose stress-related changes 
nonetheless mirror those observed in blood (Figure 1; Kirschbaum et al., 1993). This 
absolute difference between blood and salivary cortisol is attributable to the lipophilic 
layers of the capillary and epithelial cell tissue that seem to act as a filter for the 
protein-unbound fraction of steroid hormones in blood (Gröschl, 2008). Thus, salivary 
cortisol has become a widely-acknowledged proxy for the bioactive fraction of 
circulating cortisol in humans (Kirschbaum & Hellhammer, 1994, but see also Levine 
et al., 2007). Accordingly, it served as an ideal basis to investigate the predictive 
value of cortisol as an intermediate (or endo-) phenotype of stress-associated health 
outcomes like psychological disorders (e.g., depression), and a large variety of 
metabolic, and cardio- or neurovascular diseases (see Chrousos, 2009, for an 
overview). 
 
1.1. Biometric challenges 
 
Irrespective of any conceptual utility of the cortisol stress response for diagnostic 
purposes, the appropriate measurement of the underlying psychophysiological 
processes is still a subject of scientific debate. This is because the many time-
specific cortisol concentrations C(t) that are observed within i individuals need to be 
statistically integrated into a few time-invariant process parameters ϕi, which can then 
be related to the outcome of interest. To this end, several purpose-designed 
parametric models have been proposed to adequately describe the change of C(t) in 
the specific phases of the cortisol stress response (e.g. piecewise growth curve 
models; Schlotz et al., 2011, Lopez-Duran, Mayer, & Abelson, 2014, or 
autoregressive free curve models; Miller et al., 2013). A key advantage of these 
models relates to their hierarchical structure, which shrinks extreme manifestations of 
ϕi towards their conditional mean and thereby improves the models’ predictive 
accuracy (see Gelman et al., 2014). Nonetheless, the penetrance of these models in 
research on the cortisol stress response has been quite limited which is presumably 
promoted by a perceived low prospective gain in predictive accuracy that is weighted 
against the considerable implementation burden of hierarchical data modeling. 
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Thus, most research on the cortisol stress responses still relies on two-stage 
procedures that involve the estimation of ϕi using the non-compartmental 
pharmacokinetic analyses on the 1st stage (e.g. calculation of the area under the 
concentration-time curve, AUC; Pruessner et al., 2003, Gabrielsson & Weiner, 2012), 
and to subsequently predict outcomes by these ϕi on the 2nd stage. 
Because of the very high precision of biochemical assays, these appealingly simple 
two-stage procedures are not considerably affected by the attenuation of potential ϕi-
outcome associations that would likely occur with psychometric stress markers (see 
Skrondal & Laake, 2001). However, high measurement precision does not 
completely alleviate the risk that inappropriate choices of ϕi will limit the statistical 
inferences that can be made: 
 
(1) The predictive accuracy of ϕi towards an outcome (and the statistical power to 
detect such associations) decreases as the portion of any outcome-unrelated 
variance in ϕi increases (Hutcheon et al., 2010). Therefore, potential 
associations will nonetheless attenuate whenever ϕi is indicative of a mixture 
of unrelated processes, but only one of these processes is actually associated 
with the outcome of interest. 
(2) The interpretability of outcome associations with ϕi is bound to the 
physiological validity of the underlying process model (i.e., the purity of the 
chosen ϕi). For instance, higher AUCs do not necessarily imply an increased 
magnitude of the cortisol stress response, but could as well be attributed to 
differences in basal, stress-unrelated cortisol secretion (Balodis et al., 2010). 
 
To evaluate the impact of these potential complications, several studies investigated 
the correlation structure of different ϕi using principal component analyses 
(Fekedulegn et al., 2007; Khoury et al., 2015). These studies found that the majority 
of variance in the parameters ϕi of non-compartmental pharmacokinetic analyses 
(i.e., 79-93%) can be attributed to two distinct biometric components of which the first 
probably represents the overall secretion of cortisol across time. By contrast, only the 
second, considerably smaller component seems to be indicative of the specific 
cortisol change in response to phasic events (such as an exposure to acute stress), 
that is not adequately reflected by many of the currently used ϕi (e.g. Khoury et al., 
2015). An accurate interpretation of outcome associations with regard to the different 
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physiological processes that are involved in the cortisol stress response further 
remains to be challenging, because many ϕi only serve to describe the apparent 
change of cortisol concentrations. However, they have not been validated against the 
parameters of a physiologically plausible model that mechanistically accounts for the 
underlying stress-related and stress-unrelated process components of HPA axis 
activity. 
 
1.2. Research aims 
 
Proceeding from the outlined biometric challenge of measuring the processes 
underlying the cortisol stress response, the present article seeks (A) to develop a 
benchmark model that is informed by pharmacokinetic theory and can therefore 
serve to infer the different physiological processes governing cortisol secretion in 
temporal proximity to acute stress exposure. Using the information provided by this 
model, this article further seeks (B) to accurately assess the validity of the various 
non-compartmental parameters ϕi that are commonly used to investigate the relation 
between these physiological processes and outcome variables of interest. 
To achieve aim (A), the research findings and those foundations of the 
pharmacological compartment theory (Gabrielsson & Weiner, 2006; Bonate, 2011), 
that are most relevant to the modeling of cortisol secretion under basal and challenge 
conditions, will be summarized. Based on these foundations, a hierarchical 
differential equation model of the cortisol stress response is developed. In contrast to 
the above-mentioned growth curve models of the cortisol stress response, this novel 
model is inherently continuous (i.e., it accounts for the partially stochastic change of 
cortisol concentrations at any point in time; Voelkle et al., 2012) and adequately 
incorporates knowledge about the physiology of the HPA axis. Specifically, the model 
is supposed to yield a set of different parameters ϕi that are interpretable as the four 
following interindividually varying process components of acute cortisol secretion: 
 
(1) the elimination of salivary cortisol from the organism, which determines a 
latent steady state of salivary cortisol that is approached in the absence of 
stress or other secretory pacemakers (i.e., recovery) 
(2) the stress-unrelated deviation of salivary cortisol from this latent steady state 
at the beginning of the sampling period 
(3) the magnitude of the cortisol stress response (i.e., reactivity) 
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(4) the temporal delay of this response relative to the onset of stress exposure 
 
Besides these deterministic process components, further stress-unrelated 
fluctuations of cortisol concentrations can occur throughout the sampling period and 
are accounted for by stochastic components. Thus, the developed model is not 
thought to be exhaustive, but only represents a simplified approximation to the most 
important physiological processes that operate before and after stress exposure. In 
consequence, the model necessarily disregards other well-known characteristics of 
HPA axis activity (e.g. circadian oscillations; Spiga et al., 2014) that cannot be 
identified by the salivary cortisol data of 210 mixed-sex individuals to which it will be 
subsequently fitted. The implications of these potential shortcomings are best 
summarized by the famous aphorism “Remember, all models are wrong; the practical 
question is, how wrong do they have to be to not to be useful” (Box & Draper, 1987, 
p. 74). 
The usefulness of the developed model will be primarily shown with respect to aim 
(B): Proceeding from the notion that the fitted model covers the involved 
physiological processes (1) to (4) sufficiently well, artificial cortisol data are 
generated, which are representative of the study design characteristics commonly 
encountered in endocrine stress research. These data are then submitted to non-
compartmental analyses and the correspondence of the resulting parameters to 
those of the data-generating model is assessed. Finally, a bootstrap is performed to 
demonstrate that the statistical power to detect the commonly observable sex 
difference in the magnitude of the cortisol stress response (i.e., males > females; 
Kudielka et al., 2009) is considerably reduced if ϕi is contaminated by variance from 
the remaining, stress-unrelated process components. 
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2. Developing a model of the cortisol stress response 
 
Psychophysiological stress responses are obviously determined by processes 
comprising both, physiological and psychological characteristics. From a process 
modeling perspective, the psychological stress level of an individual is often thought 
to increase through accumulation in a psychological reservoir if environmental 
challenge occurs repeatedly or persists across time (e.g.  Deboeck & Bergeman, 
2013). In the absence of environmental challenge, by contrast, the stress level 
decreases across time because compensatory processes provide the individual with 
the constant ability to empty the reservoir. The dependency of the manifest stress 
level on these accumulation and dissipation processes in the basic reservoir model is 
schematically visualized in Figure 2. 
 
 
Figure 2. Basic reservoir model of stress / cortisol at time t (Deboeck & Bergeman, 2013, Psychological 
Methods, 18, p.269, APA, adapted with permission). 
In pharmacological theory, such reservoirs are also known as compartments, that is, 
spatially separable components of a physiological system in which the concentration 
of a substance can be determined. Essentially, blood and saliva form such 
compartments1, which is the primary reason for relying on this terminology when 
cortisol concentrations are modeled. 
                                               
1 Notably, compartments are usually characterized by a specific volume in which a 
substance is homogeneously distributed. The distribution volume V can be 
determined by injecting a known amount of substance into and measuring the 
resulting concentration in that compartment (e.g., a substance dose of 1 mmol that 
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Because cortisol serves as a stress biomarker, it seems reasonable to assume that 
its concentration changes through similar mechanisms as in the reservoir model. 
Thus, the accumulation of cortisol in a monitored compartment could be attributed to 
secretion processes (e.g., input due to stress exposure), which would be 
counteracted by the concurrent elimination (e.g., output due to the metabolization 
and excretion) of cortisol from that compartment. Such inputs and outputs can be 
described using ordinary differential equations (ODEs) that formalize the relative 
change of substance concentration dC per unit of time t (Gabrielsson & Weiner, 
2006, p.105ff). The ODE of the outlined input-output model is provided below in Eq. 
1, which is subject to the initial concentration C(0): 
 
Eq. 1 𝑑𝐶(𝑡)𝑑𝑡 = 𝑘(𝑆(𝑡) − 𝑘+𝐶(𝑡) 
 
The first term of this model kSS(t) represents the secretion processes, where S(t) is 
an unknown function which determines the magnitude of cortisol secretion at a 
specific point in time, that is, S(t) simply serves as a multiplier of the secretion rate 
kS. Accordingly, stress events could for instance unfold their phasic effects on kS 
through a step-function so that S(t) > 0 when stress is going, and S(t) = 0 under 
resting conditions. In the context of the cortisol stress response, however, such step-
functions are probably too simple. Therefore, the subsections 2.1 – 2.4 will devise a 
physiologically plausible parametric form of S(t). 
The second term of this model kEC(t) represents the elimination processes that 
operate on the cortisol concentration C(t) irrespective of any stress-related alteration 
of kS. Here, kE denotes the so-called fractional turnover rate of cortisol, that can also 
                                                                                                                                                  
results in a blood serum concentration of 0.2 mM suggests that V = 1 mmol / 0.2 
mmol*litre-1 = 5 litres). Yet, V does not reflect a physical property, because 
compartments vary extremely in their capability to contain specific substances. For 
example, the mean effective distribution volume of the blood compartment amounts 
to V = 450 liters for bioactive cortisol (Buning et al., 2017), because its major fraction 
binds to carrier proteins (predominately corticosteroid-binding globulin and albumin; 
Lentjes & Romijn, 1999). In the present article, however, the amount of secreted 
cortisol is unknown and V therefore becomes a quantity of minor relevance. 
Miller et al. (in press). https://doi.org/10.1016/j.psyneuen.2017.12.019 
	 10	
be used to calculate the mean residence time of cortisol as MRT = loge(2) / kE (i.e., 
the average time that a cortisol molecule remains in the organism after its synthesis). 
 
2.1. Tonic versus phasic cortisol secretion: The „baseline“ assumption 
 
An appealing feature of the outlined model is its capability to account for situations in 
which the input into the monitored compartment occurs not only in response to 
phasic stress events, but also due to a tonic, stress-unrelated secretion process, that 
results in the maintenance of a constant steady-state (or basal) cortisol concentration 
C(t) = CSS under resting conditions. From a physiological point of view, the existence 
of such a CSS seems to be very likely due to a non-zero availability of the peptide 
hormone ACTH, which continuously enables the entry of cholesterol into the adrenal 
glands where it will be subsequently converted to cortisol (Spiga et al., 2014). The 
ODE representation of the input-output model implies that C(t) = CSS when cortisol 
concentrations stop to change across time dC = 0, that is, the CSS is determined by 
the full equilibration of cortisol secretion and the elimination processes: 
 
Eq. 2 𝑑𝐶(𝑡)𝑑𝑡 = 𝑘(𝑆(𝑡) − 𝑘+𝐶(( = 0 
 
By rearranging Eq. 2, it becomes obvious that CSS depends on S(t), which 
necessarily varies across time under conditions of ongoing phasic change. Under 
resting conditions with S(t) = 1 by contrast, the time-invariant steady-state 
concentration can simply be calculated as CSS = kS / kE, so that kS becomes 
interpretable as the basal secretion rate. 
In order to combine the necessity of a time-varying S(t), with the physiologically 
reasonable assumption of a CSS, an according extension of the input-output model 
can be implemented by conceiving S(t) as two additive subprocesses of phasic and 
tonic secretion S(t) = S*(t) + 1. The change of cortisol in the monitored compartment 
is then given by 
 
Eq. 3 𝑑𝐶(𝑡)𝑑𝑡 = 𝑘((𝑆∗(𝑡) + 1) − 𝑘+𝐶(𝑡) 
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Importantly, the time-invariant steady-state concentration CSS is not necessarily equal 
to the initial pre-stress concentration C(0), that is often referred to as “baseline” 
cortisol. Although the assumption that CSS = C(0) seems to be intuitively plausible 
whenever the time before stress exposure can be considered as a resting period, 
most studies of the cortisol stress response find that C(t) drops below C(0) in the 
majority of participants (e.g. Kirschbaum et al., 1993; see Figure 1). Several 
explanations for such drops of C(t) after stress exposure have been reported 
including circadian changes of the basal secretion rate (Johnson, 2007), secretory 
rebound (Urquhart & Li, 1969, see also Gabrielsson & Weiner, 2006, p.1019ff), and 
anticipatory stress (Engert et al., 2013). 
Even in the absence of stress, however, phasic ACTH pulses are known to occur 
with a mean frequency of approximately one pulse per hour (Spiga et al., 2014). 
Given a mean cortisol half-life of t0.5 = 40 min in saliva (Perogamvros et al., 2011), 
these time intervals are not sufficient for C(t) to approach a constant CSS. This is 
probably also the reason why the existence of a steady state is no necessary 
assumption to generate plausible models of cortisol secretion (e.g. Brown et al., 
2001). Nonetheless, these random perturbations of C(t) highlight that C(0) should be 
at least allowed to deviate from a CSS to so that the confounding of the cortisol stress 
response with residual stress-unrelated phasic activity of the HPA axis can be 
avoided. 
 
2.2. Cholesterol absorption and conversion 
 
In accordance with the previous section, tonic cortisol secretion is supposed to arise 
due to the availability of tonic amount of ACTH under resting conditions, whereas 
phasic stress events cause the phasic release of an additional amount of ACTH into 
the blood stream. Specifically, the tonic amount of ACTH enables a continuous entry 
of cholesterol into the adrenal glands and therefore scales the rate of cortisol 
secretion kS under resting conditions. By contrast, phasic ACTH pulses increase the 
amount of cholesterol that enters the adrenal glands, and thereby result in a transient 
growth of kS as determined by S*(t). 
S*(t) therefore represents a time-dependent multiplier of the basal secretion rate kS 
and corresponds to the additional cholesterol in the unobservable compartments of 
the adrenal glands after stress exposure. Accordingly, an ODE model of the entry of 
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cholesterol into the cytoplasm and its subsequent transfer and conversion into 
cortisol by the mitochondria of adrenal gland tissue (Spiga et al., 2014) may serve as 
a reasonable starting point for devising the functional form of S*(t). Such a simplified 
model of cholesterol change in a virtual cytoplasm compartment and a mitochondria 
compartment is depicted in Figure 3A. The corresponding concentration-time curves 
for both of these compartments are shown in Figure 3B and 3C, respectively, and 
illustrate the following model properties: 
Initially, neither of the two compartments is assumed to contain a measurable 
amount of the cholesterol portion that is additionally absorbed in response to a 
stress-related ACTH pulse. After stress-onset at t0, the cholesterol in the cytoplasm 
compartment (Figure 3B) then instantaneously rises to the total amount that will be 
converted to cortisol in response the ACTH pulse. This abrupt event has no formal 
physiological correspondence, but only serves to implement the gradual absorption 
of cholesterol into the mitochondria compartment (Figure 3C). 
 
Figure 3. [A] Schematic model of cholesterol change that determines the transient increase of cortisol 
secretion in response to stress exposure. [B] At stress onset (t = 0 min), the amount of cholesterol in the 
cytoplasm compartment R is thought to increase immediately, but will be subsequently transferred into 
the mitochondria compartment S* at a rate kT. [C] Concurrently to its transfer, cholesterol will be 
converted in S* at a rate kA. It is the cholesterol availability in S* at time t that will finally determine the 
increase of cortisol secretion. 
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The depicted model of S*(t) postulates that the change of cholesterol in the 
cytoplasm dR only depends on rate of cholesterol transfer out of cytoplasm 
compartment kT. The corresponding process is expressed by Eq. 4. 
 
Eq. 4 𝑑𝑅(𝑡)𝑑𝑡 = −𝑘1𝑅(𝑡) 
 
 
By contrast, the time-dependent change of cholesterol in the mitochondria due to 
stress-exposure dS* is thought to depend on two different processes (i.e., cholesterol 
transfer and conversion) that are jointly formalized by the ODE below. 
Eq. 5 𝑑𝑆∗(𝑡)𝑑𝑡 = 𝑘1𝑅(𝑡) − 𝑘2𝑆∗(𝑡) 
 
As can be seen, kT concurrently represents the rate of cholesterol transfer out of the 
cytoplasm compartment and into the mitochondria compartment. Thus, the dS* will 
initially correspond to –dR as shown in Figure 3C. Importantly, this initial increase 
attenuates as less cholesterol remains in the cytoplasm compartment. Thus, the 
conversion process will start to dominate dS*. This conversion of cholesterol into 
cortisol is performed at a rate parameter kA, and implies that S*(∞) ≈ 0 (i.e., all 
additional cholesterol will be converted as time goes by) if no further ACTH pulse 
occurs. 
To enrich this basic model of phasic, stress-related cholesterol conversion by the 
tonic, stress-unrelated component, Eq. 5 can be generalized to Eq. 6 by substituting 
S*(t) = S(t) – 1: 
 
Eq. 6 𝑑𝑆(𝑡)𝑑𝑡 = 𝑘1𝑅(𝑡) − 𝑘2𝑆(𝑡) + 𝑘2 
 
The system, that is formed by the Eqs. 4 and 5/6, can be analytically solved using 
Laplace transformations, which yields the following nonlinear equation of S(t) that is 
determined by three easily interpretable parameters (see also Gabrielsson & Weiner, 
2006, p. 31): 
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Eq. 7 𝑆(𝑡) = 𝑘1𝑅(0)𝑘1 − 𝑘2 (𝑒4567 − 𝑒4587) + 1 
 
The first parameter R(0) represents the relative amount of additional cholesterol that 
will be converted in response to the stress-related ACTH pulse. Thus, it can be 
conceived as the magnitude parameter of the cortisol stress response. By contrast, 
the shape of S(t) is exclusively determined by the two rate parameters kT and kA, 
which represent the relative change of cholesterol due to the transfer and the 
conversion processes, respectively. 
 
2.3. Delay of stress-induced cholesterol conversion 
 
For didactic reasons, the previous subsection relied on the idea of a cortisol 
conversion process that operates instantaneously on all cholesterol molecules that 
enter the mitochondria compartment. However, this assumption is overly simplified 
because it disregards that the conversion of cholesterol requires a considerable 
amount of time (i.e., 10 – 15 min; Spiga et al., 2014). This indirect mode of action can 
be modeled as a delayed transfer of cholesterol into the mitochondria compartment 
after ACTH exposure. 
One approach to account for such a delay simply requires the estimation of an 
additional shift parameter µ that represents the time passing in between the onset of 
stress (fixed at t0) and the onset of the secretory response (t0 + µ). However, the 
utility of such change-point models is limited by (1) their physiological implausibility, 
and (2) difficulties in finding the best-fitting parameter set using numeric ODE solvers 
(Savic et al., 2007). Both shortcomings can be circumvented by the incorporation of n 
chained transit compartments in between R and S, which successively delay the 
cholesterol transfer from the cytoplasm into mitochondrial compartment (Bonate, 
2011, p. 331). 
Because such transit compartments are inherently unobservable, the cytoplasm 
compartment R can simply be regarded as another transit compartment, from which 
cholesterol is transferred at a similar rate kT as from the remaining transit 
compartments. Considering the lack of knowledge about the precise kinetics of the 
cholesterol transfer, the cytoplasm compartment will therefore be substituted by a 
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variable number of transit compartments (see Figure 4A). The accordingly extended 
ODE of cholesterol change in the mitochondria compartment (Eq. 6) is 
 
Eq. 8 𝑑𝑆(𝑡)𝑑𝑡 = 𝑘1𝑅9(𝑡) − 𝑘2𝑆(𝑡) + 𝑘2 
 
where Rn(t) denotes the relative amount of cholesterol in the last (nth) transit 
compartment at time t, and kT represents the rate of cholesterol transfer from the last 
transit compartment into the mitochondria compartment. 
 
 
 
Figure 4. [A] Schematic model of S(t) that accounts for a tonic, stress-unrelated cholesterol secretion (1) 
and the delay of phasic, stress-related cholesterol secretion using a variable number of transit 
compartments (R1 – Rn). [B] Depending on the transfer rate (kT) of cholesterol from one transit 
compartment to the subsequent one, the mean transit time (μ = [n+1]/ kT) of cholesterol can approximate 
a fixed delay time at which its complete amount will be transferred into the mitochondria compartment. 
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Savic et al. (2007) reported the analytical solution for Rn(t) that can be generalized to 
Eq. 9 by means of the Gamma function [n! = Γ(n + 1)]. 
 
Eq. 9 𝑅9(𝑡) = 𝑅(0) 𝑘19Γ(𝑛 + 1) 𝑡9𝑒4587 
 
After plug in of Eq. 9 into Eq. 8 it becomes clear that a specific portion of R(0) is 
transferred at each point in time as determined by the density function of the Gamma 
distribution f with a shape parameter α = n+1 and a rate parameter β = kT (see 
appendix A): 
 
Eq. 10 𝑑𝑆(𝑡)𝑑𝑡 = 𝑅(0) 𝑘19<=Γ(𝑛 + 1) 𝑡9𝑒4587>????@????AB(9<=,	58) − 𝑘2𝑆(𝑡) + 𝑘2 
 
At this point, it should be noted, that most implementations of this model rely on its 
representation using a separate linear ODE for each transit compartment (Figure 4A; 
see also Sun & Jusko, 1998). This approach comes at the cost of reduced flexibility 
because it forces n to be a discrete quantity. However, it concurrently decreases the 
time of model fitting at small n due to the linearization of Eq. 10. 
To facilitate parameter interpretability, the average time required for R(0) to be 
transferred into the mitochondria compartment can either be reported as mean transit 
time μ = (n+1)/kT or as modal transit time m = n / kT (given n > 0). By contrast the 
dispersion of the R(0) transfer with respect to time is exclusively determined by kT. 
Accordingly, μ will become the time-invariant delay parameter of the above-
mentioned change-point model, when the cholesterol transfer occurs immediately (kT 
≈ ∞ min-1), whereas a slower transfer entails a pronounced temporal spread of 
cholesterol availability in the mitochondria compartment (see Figure 4B). 
 
2.4. Stochastic volatility of cholesterol conversion 
 
So far, the developed model encompasses all specifications that are necessary to 
account for tonic and phasic, stress-related components of cortisol secretion, and the 
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likely delay of cortisol secretion after stress exposure. As mentioned in subsection 
2.1, however, ACTH pulses do not exclusively occur in response to stress but also 
due to endogenous oscillations of HPA axis activity. Although the physiological 
mechanisms underlying these oscillations are not completely understood, simulations 
suggested that they may simply emerge as a consequence of inhibition of ACTH 
secretion by cortisol and the secretory delay of cortisol conversion explained in 
subsection 2.3 (see Spiga et al., 2014, for more details). Importantly, these 
mechanisms will probably also operate in temporal proximity to stress and may 
therefore entail a misspecification bias of the parameter estimates unless 
countermeasures are taken. 
The modeling of random deviations of the cortisol concentration from its steady-state 
at baseline (subsection 2.1) is such a countermeasure that can compensate for a 
potentially biased estimation of the magnitude of the cortisol stress response R(0). 
The functional form of this S(t), however, is also determined by the number of transit 
compartments n and the transfer rate kT, which could in principle fit any endogenous 
(i.e., stress-unrelated) ACTH pulse in the post-stress period that will then be 
mistaken for a stress-related pulse. 
A parsimonious means to deal with such misspecification issues relies on the 
extension of the complete secretion model dS by a Wiener diffusion process dW/dt ~ 
N(0, w), which enables the occurrence of inert stochastic perturbations from the 
trajectory predicted by the Eq. 10 (e.g., Voelkle et al., 2012). The corresponding 
stochastic differential equation (SDE) of such an extended model is: 
 
Eq. 11 𝑑𝑆(𝑡)𝑑𝑡 = 𝑅(0)𝑓(𝑛 + 1, 𝑘1) − 𝑘2𝑆(𝑡)>???????@???????AFGHIJK +	𝑘2L7M9JK +	𝑑𝑊/𝑑𝑡>?@?APJBBQIJM9  
 
2.5. Summary of the developed pharmacokinetic model 
 
In the previous subsections, a pharmacokinetic model of the cortisol stress response 
was developed. This model was designed to provide parameters that have distinct 
physiological meanings, thereby enabling to infer the processes that govern cortisol 
secretion and elimination in temporal proximity to transient stress exposure. 
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The full model is expressed by the following ODE, which comprises the - from a 
physiological point of view - most relevant parameters to accurately describe the 
continuous change of bioavailable cortisol across time: 
 
Eq. 12 𝑑𝐶(𝑡)𝑑𝑡 = 𝑘(	𝑆(𝑡	|	𝑅(0), 𝜇, 𝑘1, 𝑘2, 𝜔)>???????@???????AIUKVU7JM9 −	𝑘+𝐶(𝑡)>?@?AUWJXJ9H7JM9 
 
where S(t) is determined by the SDE provided in Eq. 11. Notably, the model is further 
subjected to an initial condition parameter C(0), that is, the cortisol concentration at 
baseline, which may deviate from its steady-state concentration CSS = kS / kE. In sum, 
the model is therefore comprised of 7 structural parameters (+1 optional diffusion 
parameter). Table 1 lists the interpretations of these model parameters. 
 
Table 1. Model parameters and their respective interpretations.		
Parameter Interpretation 
R(0)  Magnitude of the cortisol stress response (relative to basal secretion) 
C(0)  Initial relative amount of cortisol (baseline cortisol) 
CSS Projected relative amount of cortisol at steady state 
μ Average delay for a cortisol molecule to be secreted (mean transit time) 
kT Rate of cholesterol transfer in response to stress exposure (per unit of time) 
kA Rate of cholesterol conversion (per unit of time) 
kS Rate of cortisol secretion at steady state (basal secretion) 
kE Fractional turnover rate of cortisol (per unit of time) 
w Magnitude of the stochasticity in cortisol secretion (relative to basal secretion) 
Note. CSS is not directly estimable, but completely determined by the ratio of the 
parameters kS / kE. 
 
In the following sections, all of these parameters will be estimated from the salivary 
cortisol data of 210 individuals using mixed-effects representations of the developed 
model. Accordingly, the between-subject variability in the most important model 
parameters will be quantified. The fitted model will thereafter be used to generate a 
large set of artificial cortisol stress responses from which the most popular non-
compartmental parameters will be calculated. Based on these simulations, we will 
finally assess the process purity of the different non-compartmental parameters.  
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3. Methods 
 
3.1. Sample 
 
The cortisol data that were modeled in this article are comprised of two different 
participant samples (total N = 210) that have been investigated by Engert et al. 
(2011) and Alexander et al. (2014). Both studies were approved by the local 
Research Ethics Boards and relied on the same stress induction protocol (see 
subsection 3.2). The accompanying cortisol monitoring procedures only differed with 
respect to the frequency of saliva sampling (18 samples and 7 samples per 
participant, respectively). 
By posting ads at McGill University in Montreal, Canada, Engert et al. (2011) 
recruited 50 male participants between 18 and 30 years of age who did not report a 
regular use of recreational drug (cannabis within the past two months, any other 
recreational drug within the past year) or habitual smoking (more than five cigarettes 
per week). Moreover, participants reporting chronic illness (including current 
psychosomatic disorders) or taking medication that may influence HPA axis activity 
were also excluded. By visual inspection 10 participants, who displayed prominent 
cortisol stress response (cf., Miller et al., 2013), were selected from this sample to 
evaluate the goodness of fit of the structural model component. 
In contrast, Alexander et al. (2014) recruited 200 mixed-sex participants (50% male) 
between 18 and 30 years of age with a broader educational background in Dresden, 
Germany. Exclusion criteria were current or past mental and/or physical diseases, 
medication intake (for example, psychotropic drugs, substances known to influence 
HPA-axis activity), pregnancy, an irregular menstrual cycle and a body mass index 
(BMI) <17 or >30 kg/m2. Considering the substantially larger sample size, it is 
primarily the data of these participants that informed the population variability of the 
model parameters. 
 
3.2. Procedure 
 
All participants were exposed to the Trier Social Stress Test (TSST; Kirschbaum et 
al., 1993), which is the most widely used psychological protocol to induce cortisol 
stress responses in laboratory settings (Goodman et al., 2017). The TSST is a social 
evaluative and mentally challenging test protocol that takes about 10 min for 
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completion and yields the most robust HPA axis activations when compared to other 
laboratory stressors (Dickerson & Kemeny, 2004). Specifically, the protocol 
comprises two five-minute-phases during which the participants have to complete a 
5–minute mock job interview and a 5-minute mental arithmetic task in front of an 
evaluating committee. To control for the exposure to food, stress, and physical 
exercise before starting the TSST, participants had a little snack upon arrival at the 
laboratory after which they rested for approx. 60 min (without eating or drinking 
anything but water). Since the acrophase of circadian cortisol secretion occurs 
proximate to awakening in humans (Stalder et al., 2016), the outlined procedure was 
implemented in between 1pm and 5pm, when circadian change hardly impacts on 
basal cortisol secretion. 
 
3.3. Specimen collection and biochemical analysis 
 
In the Montreal study, saliva specimens were collected in 10-min intervals before 
TSST onset (at -20, -10, and 0 min), in 2-min intervals during the TSST and the 
following 12 min (at +2, +4, +6, +8, +10, +14, +16, +18, +20, and +22 min, with the 
exception of the +12 min sample) and in 10-min intervals thereafter (at +30, +40, 
+50, +60, and +70 min). The +12 min specimen was skipped due to a lack of time for 
proper sampling when bringing participants back to their resting rooms after the 
TSST was completed. By contrast, the Dresden study employed a sparser sampling 
schedule, which yielded one specimen before TSST onset (-5 min) and six 
specimens after TSST onset (+11, +20, +30, +40, +55, and +70 min). 
Specimens were collected using Salivette® devices (Gröschl et al., 2008) and stored 
at 20°C until biochemical analysis using either a time-resolved fluorescence 
immunoassay (DELFIA, Dressendörfer et al., 1992) for the Montreal study, or a 
chemiluminescence immunoassay (CLIA, IBL International) for the Dresden study. 
Although the IBL CLIA yields approximately 80% larger cortisol concentrations as 
compared to the DELFIA, the good relative correspondence between both assays 
and a mass spectrometric reference method has been previously demonstrated 
(Miller et al., 2012). All cortisol concentrations are reported in nmol/l (nM). 
 
3.4. Statistical analysis 
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The pharmacokinetic model of the cortisol stress response that was developed in 
section 2 was implemented using the PSM package (Klim et al., 2009) and R 3.3.2 
statistical software (R Core Team, 2016). Specifically, a nonlinear mixed-effects 
approach was employed to obtain population estimates of all model parameters while 
accounting for the between-subject variability (BSV) of these parameters (cf. Gelman 
et al., 2014). A concise introduction to the mixed-effects modeling of the population 
kinetics of pharmacological substances is provided by Mould and Upton (2012, 
2013). 
 
3.4.1. Model fitting and parameter estimation 
 
The generic observation equation used for model fitting is provided below  
 
Eq. 13 𝑐J5 = 𝐶(𝑡5	|	ϕJ) + 𝜀J5 
 
Here, c represents the cortisol concentration of the ith individual that was observed at 
the kth sampling occasion. C represents the cortisol concentration that was predicted 
at time t relative to stress onset given the p-dimensional vector of model parameters 
ϕi (i.e., the individually varying solutions of Eq. 12). ϕi is determined by the population 
parameters θ = {R(0), C(0), µ, kT, kA, kS, kE, ω} (i.e., the fixed effects) and individual 
deviations ηi from these population parameters (i.e., the random effects) as ϕi = 
θ*exp(ηi). The random effects are assumed to follow a multivariate Gaussian 
distribution ηi ~ MVN(0, Ω) where Ω is a symmetric covariance matrix. Finally, εik ~ 
N(0, σ) represents the normally distributed, additive residuals that are comprised of 
variance σ2 due to measurement and misspecification error. 
All model parameters Ψ = {θ, Diag(Ω)0.5, σ} were estimated by maximization of the 
models linearized likelihood function LL(Ψ | c, t) (Wang et al., 2007). To this end, C 
was determined using a numerical differential equation solver (Soetaert et al., 2010) 
that was coupled to a Fortran-coded Kalman filter (see Donnet & Samson, 2013, for 
an overview of different methods to estimate mixed-effects SDE models). The 
employed first-order conditional estimation (FOCE) algorithm involved two alternating 
optimization steps of which the first outer step served to find the most likely θ, 
whereas the second inner step maximized the posterior probability of ηi given Ψ. 
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Notably, this analysis pipeline was previously validated against the proprietary 
software NONMEM (Klim & Mortensen, 2008). 
Robust standard errors and the 95% confidence intervals of all parameters were 
estimated by winsorized case bootstrapping (Yafune & Ishiguro, 1999; Ette & Onyiah, 
2002)2. As each of the 250 employed bootstrap replicates required a fitting time of 
~1.5 hours, the procedure was parallelized across 50 cores of the Linux server 
cluster of the Department of Medical Epidemiology and Biostatistics at Karolinska 
Institutet, Stockholm.  
 
3.4.2. Model specification and comparison 
 
The modeling procedure started with the fitting of the structural model part (i.e., no 
BSV and stochastic volatility of the secretion process were allowed) that was 
enriched by two further parameters to account for the relative measurement 
discrepancy between both assay methods, and the well-known difference between 
the magnitude of the cortisol stress response R(0) in males (Montreal + Dresden) 
and females (only Dresden). Proceeding from the resulting parameter estimates, 
population models were generated by successively estimating the (residual) BSV of 
R(0), kE, kT, and C(0). Finally, the stochastic volatility parameter ω was added. The fit 
of these models was compared using likelihood ratio tests and Akaike weights 
(Vandekerckhove et al., 2015), and further evaluated by visual predictive checks 
(Mould & Upton, 2013). The compiled cortisol data, and the commented syntax for 
the specification, fitting, and comparison of all models can be downloaded from 
https://osf.io/ecjy6.  
                                               
2 One complication with the fitting of SDE models is, that numerical optimization 
algorithms often fail to find the global minimum. This is because the stochastic 
volatility term roughens the likelihood surface and thereby inflates the fit of many 
different parameter sets that would otherwise not have adequately accounted for the 
data. In such situations, the approximate Hessian is commonly not positive definite 
and can therefore not be used to infer on the sampling variance of the parameters. 
Case bootstrapping provides a solution to this issue. 
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4. Results 
 
4.1. Pharmacokinetic modeling of stress-related cortisol secretion 
 
Population pharmacokinetic modeling of cortisol concentrations in saliva before and 
after stress exposure was conducted as described in the subsection 3.4, using the 
SDE model developed throughout section 2 of the present article. The descriptive 
statistics of these cortisol data from 10 male participants (Montreal sample) and the 
200 mixed-sex participants (Dresden) are listed in Table 2. 
 
Table 2. Moments and quantiles of cortisol concentrations, stratified by sample. 
Time Mean SD Skewness Min Q25% Q50% Q75% Max 
Montreal (N = 10) 
-20 4.01 1.26 0.33 2.38 3.08 3.94 4.84 6.40 
-10 3.66 1.34 1.78 2.37 3.24 3.36 3.65 7.24 
0 4.51 2.48 0.87 1.63 3.10 3.66 5.53 9.97 
+2 4.49 2.46 0.62 1.46 2.89 3.93 5.62 9.15 
+4 4.90 3.21 1.23 1.41 3.01 4.21 5.78 12.71 
+6 4.88 2.88 0.74 1.24 2.99 4.58 5.50 10.89 
+8 5.69 3.61 0.63 1.68 2.76 5.09 6.86 12.53 
+10 6.51 4.95 0.95 1.62 3.05 5.46 6.79 16.66 
+14 8.28 4.93 0.64 2.90 4.56 7.27 9.87 17.84 
+16 10.08 5.11 0.71 4.11 7.51 9.27 10.75 19.43 
+18 10.95 3.90 0.64 5.89 8.57 9.89 11.85 18.06 
+20 11.77 3.46 0.35 7.00 9.75 11.33 13.07 17.80 
+22 12.48 3.14 1.03 9.50 10.18 11.69 13.83 19.56 
+30 9.18 2.42 0.11 5.31 7.45 9.19 10.45 13.27 
+40 6.57 2.02 -0.27 2.77 5.66 6.72 7.29 9.56 
+50 5.15 1.41 -0.96 2.03 5.10 5.31 6.11 6.69 
+60 4.37 1.38 -0.45 1.61 3.52 4.52 5.10 6.46 
+70 3.48 1.04 -0.53 1.41 3.07 3.82 3.91 5.11 
Dresden (N = 200) 
-5  10.26 5.63 1.72 2.16 6.24 8.79 12.65 42.47 
+11 15.51 8.32 1.04 4.20 9.11 13.39 19.99 47.34 
+20 21.88 11.64 0.70 4.79 12.35 19.86 29.59 59.42 
+30 21.61 12.67 0.90 3.90 11.64 19.31 28.79 63.33 
+40 17.82 10.37 1.09 3.60 10.26 15.40 23.40 56.63 
+55 13.52  6.91 0.84 2.82 8.12 12.62   17.38 34.92  
+70 11.19 5.46 0.95 2.78 6.94 10.05 14.30 30.18 
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4.1.1. Structural model 
 
In a first step, the pharmacokinetic model was fitted to the data without assuming any 
between-subject variability (BSV) of model’s parameters within the investigated 
population or stochastic volatility of the secretion process. In order to account for the 
systematic differences in salivary cortisol a priori, the model was additionally 
informed by (1) a scaling factor λ, that estimated the relative discrepancy between 
cortisol concentrations measured by the CLIA versus the DELFIA method (Miller et 
al. 2012), and (2) participant sex, which was included as the strongest magnitude 
predictor of the cortisol stress response (Kudielka et al., 2009)3. 
As explained in subsection 2.3, the expected delay of the stress-related increase in 
cortisol due to its de-novo synthesis from cholesterol can be easily modeled using 
transit compartments. Accordingly, different model variants comprising 0 ≤ n ≤ 6 
transit compartments were evaluated with regard to their capability to approximate 
the shape of stress-related cortisol synthesis. The Akaike weights of these model 
variants are visualized in Figure 5A, and illustrate that more than n = 3 transit 
compartments did not further decrease the deviance between the fitted model and 
the observed cortisol concentrations. Accordingly, the model yielded a maximal 
deviance of -2LL = 11250.9 when n = 0, and a minimal deviance of -2LL = 11181.9 
when n = 3 transit compartments were included. 
Figure 5B shows the mean observed salivary cortisol concentrations, and their 
corresponding trajectories as predicted by the best fitting (n = 3) model. The 
parameter estimates of this model and their bootstrapped 95% confidence intervals 
are listed in Table 3 (column A). While the magnitude of the cortisol stress response 
was estimated to be approximately twice as large in males (R(0)male  = 55.9) as 
compared to females (R(0)female = 28.1 ~ 0.5*R(0)male), the cortisol concentrations that 
were measured using the CLIA amounted to the λ = 2.5-fold of those measured using 
the DELFIA method. 
                                               
3 To investigate the possibility that sex differences in the cortisol stress response 
may not be exclusively attributable to the magnitude of stress-related cortisol 
secretion, the model parameters C(0), kT, and kE were also regressed on the 
participants’ sex. However, neither the corresponding coefficients nor the likelihood 
ratio (c2(3) = 0.183, p = 0.98) suggested the presence of further significant sex effects. 
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Figure 5. (A) Comparison of structural models with different numbers of transit compartments. (B) 
Salivary cortisol in the Montreal and the Dresden samples. Means (± 95% CIs) of observed cortisol are 
indicated by points, whereas the dashed lines show the cortisol trajectories predicted by the structural 
model with n = 3 transit compartments. (C) Goodness-of-fit plot of salivary cortisol as predicted by the 
fully parameterized ordinary population model (ODE) and the stochastic population model (SDE). (D) 
Comparison of the cortisol secretion functions predicted by both models in two exemplary males from 
Montreal. 
All following parameter estimates are based on the DELFIA method because it was 
previously shown to correspond closely to mass spectrometric reference assays 
(Miller et al., 2012): At steady state the mean cortisol secretion amounted to kS = 
0.38 nM*min-1. As the corresponding fractional turnover rate of cortisol was estimated 
kE = 0.09 min-1, the model implied a mean residence time of MRT = 7.7 min and a 
mean steady state concentration of CSS = kS/kE = 4.20 nM. In response to stress, 
however, the cortisol secretion reached an average rate of 1.72 nM*min-1 in males 
and 1.06 nM*min-1 in females when the peak of the secretion function was reached at 
m = n / kT = 10.7 min (mean transit time: μ = (n+1) / kT = 14.2 min). 
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4.1.2. Ordinary population model 
 
Proceeding from the above reported results, the number of transit compartments was 
set to n = 3. In a second step, the structural model was sequentially extended by 
estimating the BSV of the secretory magnitude R(0), the fractional turnover rate kE, 
the transfer rate kT, and finally the initial concentration C(0) = kS / kE. Table 3 lists the 
results of these analyses (column B-E). Notably, the precision of the fixed effects 
estimates increased substantially as compared to the structural model without BSV. 
R(0) in females reduced further from 50% to 36% of the stress-related secretory 
magnitude in males. Moreover, kT and kA approached a similar numerical value. The 
goodness of fit of the fully parameterized population model is shown on Figure 5C. 
Each of the added random effects accounted significantly for an incremental portion 
of variance in salivary cortisol and finally yielded R2 = 97% (-2LL = 8404.6). Appendix 
B shows that this outstanding fit reflects the model’s ability to selectively capture the 
most important process components of the stress-induced cortisol change while 
preserving a sufficiently low model complexity. 
The BSV of R(0) explained by far the largest portion of variance in salivary cortisol 
(DR2 = 53%), with a 95% range from the 0.16 to the 6.21-fold of its sex-specific 
median manifestation. The BSV of kE and kT implied mean residence times of cortisol 
between MRT = 5.1 – 17.2 min, and mean transit times of cholesterol between μ = 
7.2 – 42.8 min, respectively. Finally, the 95% range of initial concentrations was 
predicted to comprise cortisol concentrations from 1.7 – 12.5 nM (as measured by 
the DELFIA method). 
Irrespective of the excellent fit of the full population model, the residual portion of 
cortisol variance suggested a coefficient of variation (CV) of 8% at 20 nM (and 16% 
at 10 nM). Considering the very high precision of modern immunoassays for cortisol 
(CVs < 6%; see Gatti et al., 2009), however, such large CVs are unlikely to be 
exclusively attributable to measurement error, but probably arise from the failure to 
completely account for non-random (temporally stable) deflections from the predicted 
cortisol trajectories. Detailed plots of the estimated secretion functions, the predicted 
trajectories, and the observed data of all 210 participants are presented in 
appendices C/D. 
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Table 3. Pharm
acokinetic m
odels (A-F) of the cortisol stress response and their respective param
eters. 
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  R(0)M
ale  
55.92 
[44.01, 67.83] 
72.50 
57.48 
55.83 
51.61 
[45.73, 57.49] 
40.90 
[33.67, 48.13] 
  R(0)Fem
ale  
28.05 
[20.28, 35.05] 
36.73 
29.12 
31.57 
18.61 
[14.91, 22.27] 
21.56 
[19.06, 24.03] 
		C
(0) = C
SS  
4.20
✝ 
[3.37, 5.03] 
3.80
✝ 
4.22
✝ 
4.01
✝ 
4.64
✝ 
[4.42, 4.85] 
4.29
✝ 
[3.88, 4.65] 
		µ	
14.21
✝ 
[12.39, 16.59] 
8.93
✝ 
11.64
✝ 
12.53
✝ 
17.57
✝ 
[16.28, 19.02] 
18.28
✝ 
[15.25, 22.76] 
  k
T  
0.28 
[0.24, 0.32] 
0.45 
0.34 
0.32 
0.23 
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0.22 
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  k
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0.05 
0.06 
0.21 
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0.21 
[0.12, 0.29] 
  k
S  
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0.37 
0.57 
0.54 
0.34 
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0.38 
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  k
E  
0.09  
[0.08, 0.10] 
0.10 
0.14 
0.14 
0.07 
[0.07, 0.08] 
0.09 
[0.06, 0.12] 
		λ 
2.46  
[1.99, 3.00] 
2.16 
2.25 
2.46 
1.92 
[1.85, 1.97] 
2.16 
[1.95, 2.41] 
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		R(0) 
0
✝  – 
1.15 
0.46 
0.40 
0.87 
[0.74, 1.00] 
0.57 
[0.33, 0.82] 
		C
(0) 
0
✝  – 
0
✝ 
0
✝ 
0
✝ 
0.25 
[0.24, 0.27] 
0.18 
[0.14, 0.21] 
  k
T  
0
✝ 
– 
0
✝ 
0
✝ 
0.21 
0.21 
[0.18, 0.24] 
0.08 
[0.06, 0.10] 
  k
E  
0
✝ 
– 
0
✝ 
0.11 
0.08 
0.10 
[0.08, 0.11] 
0.10 
[0.06, 0.15] 
R
esidual variability 
 
 
 
 
 
 
 
 
 
		σ 2 
69.36 
[56.45, 82.26] 
16.56 
12.43 
10.61 
2.62 
[2.39, 2.84] 
0.64 
[0.50, 0.79] 
		ω
 
0
✝ 
– 
0
✝ 
0
✝ 
0
✝ 
0
✝ 
– 
0.37 
[0.34, 0.40] 
M
odel fit 
 
 
 
 
 
 
 
 
 
  R
2 
0.31 
0.84 
0.88 
0.89 
0.97 
0.99 
  LL 
-5590.9 
-4785.2 
-4651.0 
-4572.5 
-4202.3 
-4187.1 
  A
IC 
11197.9 
9588.3 
9322.0 
9167.1 
8428.6 
8400.2 
Note. ✝fixed / constrained param
eter. M
odel (A
) represents the structural m
odel. M
odels (B
-E) estim
ate the betw
een-subject variability (B
SV
) in 
som
e of these structural param
eters. M
odel (F) further allow
s for stochastic perturbations of the cortisol trajectories. 
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4.1.3. Stochastic population model 
 
In a final step, the portion of error-related residual variance was separated from true 
stochastic perturbations of the secretion process (i.e., residual autocorrelation) that 
were not accounted for by the ordinary population model. Table 3 (column F) lists the 
corresponding parameter estimates and their bootstrapped 95% confidence intervals. 
Due to the additional stochastic component, the model-implied residual CV reduced 
to 4% at 20 nM (8% at 10 nM), which conforms with the assay precision that can be 
expected based on previous findings (Gatti et al., 2009). This reduction of residual 
variance is also reflected by the goodness of fit plot in Figure 5C. Noteworthy, the 
stochastic volatility parameter ω accounted for a considerable portion of cortisol 
variance that was previously attributed to BSV in the magnitude of stress-related 
cortisol secretion (-34.5% in R(0)) and transit rates (-61.9% in kT), whereas the 
variability in the fractional turnover rates hardly changed (+6.9% in kE). Conversely, 
the estimates of some fixed effects were also adjusted. 
The outlined effect pattern supports the idea that the stochastic population model 
was actually able to compensate for misspecification bias due to mechanistic 
simplifications in its nested ordinary population model. Proceeding from existing 
psychophysiological knowledge, such simplifications could relate to anticipatory 
stress (Engert et al., 2013) or different sources of secretory rebound (Urquhart & Li, 
1969; Spiga et al., 2014) that lead to response asynchrony and the oscillatory 
secretion patterns after stress cessation illustrated in Figure 5D. 
In support of these alleged benefits of the stochastic population model, Figure 6 
further highlights its predictive accuracy as compared to the ordinary population 
model: While the 95% concentration range predicted by the ordinary model 
corresponds quite well to the time-specific distribution of cortisol in females, it 
substantially overestimates the dispersion of cortisol in males. By contrast, the 
predictions of the stochastic model correspond much better to the observed data. 
This is also because the ordinary model suggests a much larger sex difference in the 
magnitude of stress-related cortisol secretion [R(0)female = 0.36*R(0)male] as compared 
to the stochastic model [R(0)female = 0.53*R(0)male], which yields an effect that was 
much closer to the original estimate of the structural model without BSV. 
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Figure 6. Visual checks of model predictions for (A) females and (B) males from Dresden. Points 
represent the observed median concentration, whereas the error bars encompass the IQR (i.e., the range 
from 25% – 75% quantile) of observed salivary cortisol. The violins and the shaded regions encompass 
the range from the 2.5% – 97.5% quantile of observed and model-implied salivary cortisol, respectively. 
ODE = ordinary differential equation, SDE = stochastic differential equation 
4.2. Comparison of model-based and non-compartmental analyses 
 
4.2.1. Correspondence between different parameters 
 
In order to investigate if cortisol concentrations at specific points in time and their 
commonly encountered non-compartmental parameters (see Khoury et al., 2015) 
actually reflect the different process components of the cortisol stress response, a 
simulation study was performed. Proceeding the fitted stochastic population model 
(section 4.1.3), we simulated the cortisol trajectories of 10,000 virtual individuals 
(50% females) during the time period from -20 min to 80 min relative to TSST onset 
(sampling interval: 2 min). Accordingly, we obtained 50 by 10,000 artificial cortisol 
concentrations (DELFIA method). 
The time-dependent rank correlations between these cortisol concentrations and 
each of the four inter-individually varying parameters of the data-generating model 
are shown in Figure 7A. C(0), R(0), and kE correlated substantially (|r’s| ~ 0.7) with 
salivary cortisol at -20 min, 20–30 min, and 50–80 min, respectively. By contrast, kT 
was hardly correlated with salivary cortisol at any point in time (|r’s| < 0.3). 
Table 4 provides a complete list of all investigated non-compartmental parameters 
(incl. their population characteristics) that were calculated from these cortisol data. 
Most of these parameters were adopted from the literature review of Khoury and 
colleagues (2015), who claimed that the correlation structure of these parameters 
was primarily attributable to two distinct biometric components representing total 
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cortisol secretion, and the stress-related secretory change, respectively. Beyond of 
this empirical finding, however, the data-generating model further implied the 
existence of two additional, meaningful variance components that reflect the delay of 
the cortisol stress response, and the initial deflection of cortisol levels from their 
steady state. As these two remaining components were insufficiently represented by 
the non-compartmental parameters that were investigated by Khoury et al. (2015), 
the cortisol concentration at the beginning of the sampling period (Cinit) and the time 
of the concentration peak (Tmax) were also determined (Fekedulegn et al., 2007). 
 
Figure 7. (A) Correlations between salivary cortisol at time t and the four parameters of the SDE model 
comprising between-subject variability. (B, C) Loadings of various parameters obtained by non-
compartmental analysis (black; see Table 4) and the data-generating SDE parameters (blue) on their first 
four principal components. 
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In accordance with the outlined reasoning, a principal component analysis indicated 
that 83% of the correlation between all of these parameters could be explained by 
four orthogonal variance components with a RMSR = 0.06. The eigenvalues of all 
further components fell below Kaiser-Guttman criterion and the limit determined by 
parallel analyses of uncorrelated variables (Humphreys et al., 1975). After varimax 
rotation, the first four components were interpretable as (1) magnitude of stress-
related cortisol secretion (or reactivity), (2) steady state concentration arising from 
the equilibration of basal cortisol secretion and elimination (or recovery), (3) secretory 
delay, and (4) stress-unrelated fluctuation of the initial cortisol concentration. 
The loadings of each parameter on these four components are visualized in Figure 
7B/C, and confirm that the non-compartmental parameters MaxMin, React, and AUCi 
(cf. Table 4) were good proxy measures of R(0), whereas Cmin was the only suitable 
proxy of kE. This latter finding is particularly interesting, because the time of Cmin 
occurred in 43% of all cortisol responses up to 60 min after stress offset, indicating 
that the steady state of salivary cortisol is quite often not appropriately indexed by a 
single “baseline” concentration like Cinit. Instead, Cinit was an exclusive proxy 
measure of C(0) because any phase-asynchronous, stress-unrelated secretory 
activity had necessarily subsided when the recovery phase was reached (see also 
Figure 7A). 
Finally, kT was best indicated by Tmax, although this association was sensitive to 
sampling frequency: Since 50% of all cortisol peaks occurred in between 20 min ≤ 
Tmax ≤ 32 min, an increase of the sampling interval to 15 min resulted in a 
considerable decrease of correlation ∆r(kT, Tmax) = 0.07. Although the kT-associated 
parameters Recov and Recov% were less sensitive as compared to Tmax, they 
exhibited substantial cross-loadings on the 1st (or the 2nd) component which 
disqualified them as appropriate proxy measures. The correlation decrease of the 
other surrogates under conditions of lower sampling frequencies was mostly 
negligible except for ∆r(R(0), MaxMin) = 0.05.  
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Table 4. Descriptive statistics of various param
eters from
 non-com
partm
ental analyses that have been com
piled from
 
10,000 sim
ulated cortisol stress responses (first sam
ple: -20 m
in relative to TSST onset, sam
pling interval: 2 m
in), and 
their associations w
ith the param
eters of the data-generating population SDE m
odel. 
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een 0 and 60 m
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(1) The 
integral of the concentration-tim
e curve is approxim
ated using the trapezoidal decom
position of the 
linearly interpolated concentrations (see Pruessner et al., 2003).  
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4.2.2. Statistical power for detecting parameter-outcome associations 
 
Although the above presented analyses of simulated cortisol data suggest that the 
commonly used non-compartmental parameters actually reflect the different process 
components of the cortisol stress response to a considerable extent, they also 
revealed that their variance is often not exclusively attributable to only one process 
component. This may have substantial implications for the probability to statistically 
detect associations between covariates or outcomes and these non-compartmental 
parameters. Specifically, the statistical power will reduce due to regression dilution 
(Hutcheon et al., 2010) whenever exclusively one process component drives these 
associations. However, the statistical power may occasionally increase if the chosen, 
impure non-compartmental parameter coincidentally taps into an association that is 
shared by several process components. Thus, non-compartmental parameters are 
subjected to the same advantages and disadvantages as any composite endpoint 
(Ferreira-Gonzáles et al., 2007). 
To illustrate the more likely case of regression dilution, further analyses were 
performed to determine the statistical power of various non-compartmental 
parameters to detect the above reported sex effect on the magnitude of the cortisol 
stress response (subsections 4.1). Proceeding from the results of the simulation 
study in subsection 4.2.1, the parameters Cmax, MaxMin, AUCi, and AUCg were 
assumed to be similarly indicative of the magnitude of the cortisol stress response. 
However, they substantially differed with respect to their cross-loadings on the 
remaining process components, that is, MaxMin and AUCi were found to incorporate 
substantially less variance from the other process components as compared to Cmax 
and AUCg. Accordingly, MaxMin and AUCi were hypothesized to yield a larger 
statistical power when Spearman rank correlation tests were used to infer the 
association between the participants’ sex and the magnitude of the cortisol stress 
response. By contrast, non-compartmental parameters that primarily indicated the 
other three process components (Cmin, Cinit, Tmax) were hypothesized to fail in 
detecting this sex effect. 
To avoid any possible confounding due to misspecification bias, the statistical power 
of all investigated non-compartmental parameters was determined by drawing 
100,000 bootstrap replicates per scenario from the Dresden sample. Figure 8 
visualizes the results of these analyses. Among all investigated non-compartmental 
parameters indicative of the secretory magnitude, MaxMin yielded the largest power 
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(nmale = nfemale > 23 to achieve 80%), whereas AUCg yielded the lowest power (nmale = 
nfemale > 74 to achieve 80%). The statistical power of Cmax and AUCi varied in 
between these two extremes, but surprisingly Cmax yielded a slightly larger power as 
the AUCi, although the latter was hypothesized to incorporate less variance from the 
other process components. Less surprising, the model-based R(0) estimates 
exceeded the power of all investigated non-compartmental parameter. 
 
 
Figure 8. Sample-size dependent power to detect the specific association (Spearman rank correlation with 
p ≤ 5%) between participant sex and magnitude of cortisol secretion using different proxy measures of 
cortisol secretion. The blue line represents the R(0) parameter of the developed pharmacokinetic model. 
Black lines indicate four non-compartmental parameters (MaxMin, Cmax, AUCi, AUCg) that primary 
loaded on the “secretory magnitude” component, but varied in their cross-loadings on the other 
components. Grey lines indicate the three non-compartmental parameters that were most indicative of 
the remaining three components (Tmax: secretory delay, Cmin: steady state concentration, Cinit: initial 
concentration / baseline cortisol). 
  
20 40 60 80 100
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
sample size per group
st
at
is
tic
al
 p
ow
er
R(0)
MaxMin
Cmax
AUCi
AUCg
Tmax
Cmin
Cinit
Miller et al. (in press). https://doi.org/10.1016/j.psyneuen.2017.12.019 
	 35	
5. Discussion 
 
The present article sought to address the question of how to adequately infer the 
different process components that govern cortisol secretion in response to 
psychosocial stress. While various parameters from non-compartmental analyses 
(e.g., change scores or the variants of the AUC; Khoury et al., 2015) are commonly 
used as proxies of these components, their specific validity to this end has not been 
systematically investigated, yet. Thus, a physiologically informed pharmacokinetic 
model was developed. This model was fitted to the salivary cortisol data of 210 
mixed-sex participants who completed the TSST (Engert et al., 2011, Alexander et 
al., 2014), and remarkably explained up to 99% variance in all measured cortisol 
concentrations. In contrast the previously proposed, hierarchical growth curve 
models of the cortisol stress response (e.g., Schlotz et al., 2011, Lopez-Duran et al., 
2014), this novel model was further designed to minimize the misspecification bias in 
the empirical Bayes estimates of its four interindividually varying parameters, which 
could therefore be used as a criterion to assess the validity of the commonly used 
parameters from non-compartmental analyses. 
 
5.1. Physiological validity of the model and potential extensions 
 
The minimization of misspecification bias was achieved through the estimation of 
stochastic perturbations in the cortisol secretion function by means of a Kalman filter 
that compensated for the potential mechanistic simplifications of the model. Such 
simplifications can for instance arise from the existence of higher order elimination 
kinetics. In this regard, the herein assumed first-order elimination kinetics of salivary 
cortisol relied on the consistent findings of other studies (e.g. Tunn et al., 1990, 
Perogamvros et al., 2011), whereas only the elimination of total (i.e., protein-bound + 
bioactive) cortisol in blood was previously shown to require second-order elimination 
kinetics (Kraan et al., 1997, Czock et al., 2005). In agreement with this assumption, 
the developed pharmacokinetic model accounted excellently for the change of 
salivary cortisol during the recovery phase of the Dresden sample. Notably, however, 
the 10 males from Montreal, who were subjected to a high-frequency sampling 
schedule, showed a tendency to display lower cortisol in the recovery phase than 
predicted by the structural part of model (Figure 5B). Although this finding may simply 
relate to a non-representative parameter configuration in these 10 males, it could 
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also indicate another source of mechanistic simplification, for which no previously 
published data were available: 
The secretion kinetics of the model assumed that phasic cortisol secretion during the 
reactivity phase can be mapped onto the density function of the right-skewed 
Gamma distribution. Thus, any stress-related cortisol secretion was hypothesized to 
quickly accelerate after ACTH exposure but to cease more slowly after the modal 
transit time had elapsed. However, the pronounced concentration peaks in the 
Montreal sample might be better explainable by a more flexible, left-skewed function 
(e.g. the density of the generalized Gamma distribution; see appendix A) so that the 
cortisol secretion could increase slowly after ACTH exposure, but quickly cease as 
soon as a certain concentration threshold is finally reached. Irrespective of the 
Kalman filters capability to account for this potential misspecification, its practical 
impact is probably negligible, because the precise kinetics of salivary cortisol during 
the reactivity phase can hardly be determined from the sparse sampling schedules 
that are commonly used in endocrine stress research. By contrast, other refinements 
of the structural model part (e.g. the circadian changes in the steady state 
concentration of salivary cortisol, Johnson, 2007; or feedback on the secretion rate of 
ACTH by cortisol using pharmacodynamic dose-response functions, Spiga et al., 
2014) may be more worthwhile to consider, if the residual stochasticity in stress-
related cortisol secretion should be mechanistically explained. 
To this end, however, the linearity of the differential equations constituting the model 
must be abandoned, which would tremendously increase the computational costs of 
model fitting using the implementation chosen in this article. Thus, inclined 
researchers may consider to rely on other analysis pipelines, such as WinBUGS 
(Lunn et al., 2002), or the combination of the R package PMXStan (Xiong et al., 
2015) with Stan statistical software (Gelman et al., 2016) which enable the easy 
implementation of fully Bayesian inference of the ODE/SDE model parameters (cf. 
Donnet & Samson, 2013). 
 
5.2. Process components and non-compartmental parameters 
 
The utility of the model was shown with regard to the differential correspondence 
between its four interindividually varying parameters and eleven common parameters 
from non-compartmental analyses. Associations between these parameters and 
covariates or outcome variables are often interpreted with respect to the process 
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components that underlie the cortisol stress response. However, such inferences rely 
on the assumption that these parameters are process-pure, that is, they incorporate 
variance that can be exclusively attributed to the respective component. 
Proceeding from the artificial cortisol data that were simulated using the proposed 
model, the magnitude parameter of the stress response R(0) (i.e., the “reactivity” 
component) was best reflected by the non-compartmental parameters MaxMin and 
React, whereas the delay of the stress response as determined by kT, the initial 
cortisol concentration C(0), and the steady state concentration as determined by kE 
(i.e., the “recovery” component),  were best reflected by the non-compartmental 
parameters Tmax, Cinit, and Cmin, respectively. Intriguingly, the good 
correspondence of kE and Cmin suggests that the assessment of individual 
differences in stress recovery does not necessarily require an active (and costly) 
stimulation of HPA axis activity that is followed by a long waiting period until cortisol 
concentrations have returned to their steady state. Instead, the cortisol levels under 
resting conditions (i.e., in the absence of any ultradian secretory activity) could 
probably also serve as a counter-intuitive proxy of stress recovery. 
Although the popular non-compartmental parameter AUCi (Pruessner et al., 2003, 
Stalder et al., 2016) was initially also found to predominately reflect R(0), subsequent 
power analyses regarding the detection of the well-known association between 
participant sex and the cortisol stress response (see Kudielka et al., 2009) raised 
some doubts about this assumption. Obviously, the AUCi was also comprised of 
variance from the other process components that were not related to R(0). Thus, any 
association with the AUCi should be interpreted with caution. 
A post-hoc explanation for this finding relates to the slightly different ways of how the 
AUCi was calculated from the real cortisol data of Dresden sample as compared to 
the artificial data that was obtained from the model-based simulations. While the 
simulated data allowed to calculate the AUCi using “baseline” cortisol concentrations 
at the onset of stress exposure, empiric studies commonly lack such a sampling 
occasion because their participants are already busy with stress anticipation at this 
point in time. Instead, sampling occasions prior to stress exposure are used to 
determine the “baseline” concentration (Balodis et al., 2010). Due to stress-unrelated 
ultradian activity of the HPA axis, the model predicts that such baseline data are 
more likely to be contaminated by stress-unrelated processes. Accordingly, it should 
be emphasized that any 2nd stage regression of the AUCi on a covariate of interest 
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(e.g. participant sex) relies on the rigid and often questionable assumption that a 
cortisol concentration at “baseline” Cinit will impact in a set way on all cortisol 
concentrations that are subsequently sampled after stress onset: 
 
Eq. 14 𝐴𝑈𝐶𝑖 = 𝐴𝑈𝐶𝑔 − 	D𝑡 ∗ 𝐶𝑖𝑛𝑖𝑡 = 	b` + b= ∗ 𝐶𝑜𝑣𝑎𝑟𝑖𝑎𝑡𝑒	 + 	e 
 
which is equivalent to Eq. 15, where the set impact of “baseline” cortisol is modeled 
as a regression offset Dt * Cinit: 
 
Eq. 15 𝐴𝑈𝐶𝑔 = b` + b= ∗ 𝐶𝑜𝑣𝑎𝑟𝑖𝑎𝑡𝑒 + D𝑡 ∗ 𝐶𝑖𝑛𝑖𝑡 + 	e 
 
Thus, it turns out that the assumption of a fixed “baseline” impact could be easily 
alleviated by adding Cinit as a second covariate to any regression model that 
investigates the association between R(0) as indexed the AUCg (which would 
otherwise also be contaminated by stress-unrelated secretion processes; see Figure 
7B) and the primary covariate of interest: 
 
Eq. 16 𝐴𝑈𝐶𝑔 = b` + b= ∗ 𝐶𝑜𝑣𝑎𝑟𝑖𝑎𝑡𝑒 + be ∗ 𝐶𝑖𝑛𝑖𝑡 + 	e 
 
Using this model specification for 2nd stage analyses of R(0) will likely yield a larger 
statistical power as compared to simple regressions on the AUCi (Eq. 14), and could 
therefore prove to be more useful for explaining additional BSV in the magnitude of 
the cortisol stress response. 
6. Conclusion and Recommendations 
The present article presented a physiologically plausible, differential equation model 
of the cortisol stress response that was used to reliably infer the four major process 
parameters determining the interindividually variable change of salivary cortisol due 
to stress exposure (i.e., secretory magnitude / reactivity, elimination / recovery, 
secretory delay, and stress-unrelated fluctuations). The model fitted the data 
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exceptionally well (R2 = 97-99%) and can be readily implemented using the R script 
that is provided as supplementary material to this article. 
Based on the correspondence between these model parameters and the commonly 
used non-compartmental measures of hormone secretion, we argue that the stress 
reactivity is best reflected by the difference between the individual maxima and 
minima of cortisol concentrations (MinMax), whereas stress recovery is best reflected 
by the minimal concentration (Cmin). The secretory delay and the stress-unrelated 
cortisol fluctuations are best reflected by the time of the concentration maximum 
(Tmax) and the initial concentration (Cinit), respectively. When Tmax is the non-
compartmental parameter of major interest, researchers should consider that its 
precise assessment requires a higher sampling frequency during the time period at 
which maximal cortisol concentrations can be expected (according to the 
conservative estimates of the ODE model, 95% of all peaks are supposed to occur in 
between 5 min and 32 min after the onset of stress exposure). 
Finally, the compiled results call for caution when interpreting the popular AUC 
measures of cortisol secretion because they seem to be comprised of variance due 
to stress reactivity and stress-unrelated secretory activity of the HPA axis. However, 
this confounding risk can be alleviated by statistical adjustments for Cinit. Because 
the statistical power to detect outcome-associations also relies on such analytical 
considerations, we hope that the above given recommendations will become 
valuable for future studies that seek to validly disentangle the specific process 
components of the cortisol stress response. 
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8. Appendix 
 
A. The (generalized) Gamma distribution 
 
Cox et al. (2007) report the density function of a generalized Gamma distribution 
gGamma(θ, σ, λ) that transitions into a Weibull distribution when λ = 1, or into a log-
normal distribution when λ = 0. After substitution of θ by log(μ) the density function of 
this generalized Gamma distribution (Eq. A1) can be simplified to the density function 
of a Gamma(μ, σ) distribution (Eq. A2) where λ = σ. As outlined in section 2.3, the 
average time of cholesterol to be converted in response to stress exposure is thought 
to correspond to the parameter μ. 
 
Eq. A1 
𝑓ghHXXH(𝑡|𝜇, 𝜎, 𝜆) = |𝜆|Γ(𝜆4e)σ𝑡 l 1𝜆e m𝑡𝜇no/pqors 𝑒4t =osut7vuw/x 
Eq. A2 𝑓hHXXH(𝑡|𝜇, 𝜎) = 𝑒47/vpsΓ(𝜎4e)𝑡 m 𝑡𝜇𝜎enprs 
 
By contrast, the parameterization of the Gamma distribution referred to in subsection 
2.3 is comprised of a shape parameter α = σ-2 and a rate parameter β = (μσ)-2. The 
corresponding density function of Gamma(α, β) (Eq. A3) forms the algebraic kernel of 
the product of the transfer rate kT and the time-dependent, relative amount of 
cholesterol in the nth transit compartment Rn(t) when α = n+1 and β = kT (see Eq. 10). 
 
Eq. A3 𝑓hHXXH(𝑡|𝛼, 𝛽) = 𝛽{Γ(𝛼) 𝑡{4=𝑒4|7 
 
Stacy (1962) reports a similarly parameterized variant of the generalized Gamma 
distribution gGamma(a = 1/β, d = α, p), which will become an ordinary Gamma 
distribution when p = 1, and a Weibull distribution when d = p. 
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B. Model complexity as compared to linear growth curves 
 
A generic property of overly complex models is their capability to account for data 
features that have only been generated by random noise (i.e. they easily overfit the 
data). The model complexity of linear growth curves (e.g., polynomials) is simply 
indicated by the number of model parameters because any data vector can be 
exhaustively represented as a linear combination of equal length. For the proposed 
ODE model, however, this simple heuristic is not valid because the nonlinear impact 
of its parameters constrains the covered state-space based on mechanistic 
assumptions. Accordingly, complexity of the ODE model (and its corresponding 
potential to overfit the data) is considerably lower as compared to a linear growth 
curve comprising the same number of parameters. To assess the complexity of the 
ODE model, we compared its capability to fit the permuted time series of each 
individual from the Dresden sample to the fits of different linear growth curves 
(degree 1 (linear) polynomials – degree 5 (quintic) polynomials). The Figure below 
shows these model fits (blue boxes) along with their fits to the original time series 
(white boxes). Notably, the effective complexity of the ODE model was approximately 
comparable to a linear growth curve model with 3.5 parameters. Moreover, the 
absolute increase in explained variance of real data was superior to any of the 
considered linear growth curves. 
 
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
co
ef
fic
ien
t o
f d
et
er
m
ina
tio
n:
 R
2
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
OD
E
lin
ea
r
qu
ad
ra
tic
cu
bic
qu
ar
tic
qu
int
ic
Miller et al. (in press). https://doi.org/10.1016/j.psyneuen.2017.12.019 
	 47	
 
  
 
  
Miller et al. (in press). https://doi.org/10.1016/j.psyneuen.2017.12.019 
	 48	
C. Individual cortisol secretion functions S(t) 
 
 
 
Figure B1. Cortisol secretion functions from the Montreal sample (upper panel) and the Dresden sample 
(lower panel) that have been deconvoluted using the SDE population model. 
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D. Observed and predicted cortisol concentrations of each participant 
 
 
Figure C1. Observed cortisol data and the individual cortisol trajectories as predicted by the ODE 
population model (grey lines, R2 = 97%) and the SDE population model (blue lines, R2 = 99%). The IDs 24, 
26, 32, 38, 39, 43, 53, 61, 97, and 100 denote the 10 male participants from the Montreal sample. The 
remainder forms the Dresden sample that was composed of 100 males and 100 female participants. 
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